- Home
- CGC vs STXS Comparison
CGC vs STXS Comparison
Compare CGC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- STXS
- Stock Information
- Founded
- CGC 2009
- STXS 1990
- Country
- CGC Canada
- STXS United States
- Employees
- CGC N/A
- STXS N/A
- Industry
- CGC Pharmaceuticals and Biotechnology
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CGC Health Care
- STXS Health Care
- Exchange
- CGC Nasdaq
- STXS Nasdaq
- Market Cap
- CGC 174.9M
- STXS 151.3M
- IPO Year
- CGC N/A
- STXS 2004
- Fundamental
- Price
- CGC $1.31
- STXS $2.14
- Analyst Decision
- CGC Sell
- STXS
- Analyst Count
- CGC 2
- STXS 0
- Target Price
- CGC $2.00
- STXS N/A
- AVG Volume (30 Days)
- CGC 7.7M
- STXS 282.8K
- Earning Date
- CGC 05-29-2025
- STXS 05-12-2025
- Dividend Yield
- CGC N/A
- STXS N/A
- EPS Growth
- CGC N/A
- STXS N/A
- EPS
- CGC N/A
- STXS N/A
- Revenue
- CGC $192,343,833.00
- STXS $26,918,000.00
- Revenue This Year
- CGC N/A
- STXS $25.90
- Revenue Next Year
- CGC $7.13
- STXS $60.57
- P/E Ratio
- CGC N/A
- STXS N/A
- Revenue Growth
- CGC N/A
- STXS 0.55
- 52 Week Low
- CGC $0.77
- STXS $1.54
- 52 Week High
- CGC $11.95
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- CGC 54.05
- STXS 63.79
- Support Level
- CGC $1.22
- STXS $1.93
- Resistance Level
- CGC $1.43
- STXS $2.07
- Average True Range (ATR)
- CGC 0.14
- STXS 0.09
- MACD
- CGC 0.00
- STXS 0.02
- Stochastic Oscillator
- CGC 41.38
- STXS 75.79
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.